Morphine Sulfate Capsule, Extended Release
Product Images NDC 0832-0225

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0832-0225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Morphine 01)

Chemical structure of morphine sulfate pentahydrate, showing the molecular framework including hydroxyl groups, a nitrogen atom in a methylated amine group, and sulfate with water of hydration (H2SO4 · 5H2O).*

FDA Label Image

Figure 1 (Morphine 02)

An instructional illustration showing a person opening a capsule by pulling apart its two halves over a spoon, allowing the contents to fall onto the spoon. This depicts the method of emptying the extended-release morphine sulfate capsule contents for oral administration.*

FDA Label Image

Figure 2 (Morphine 03)

An instructional illustration showing a person placing a capsule in their mouth using their fingers, demonstrating oral administration of the extended-release Morphine Sulfate capsule.*

FDA Label Image

Figure 3 (Morphine 04)

An instructional illustration showing a person holding a glass of water near their mouth, demonstrating how to take an oral capsule medication.*

FDA Label Image

Figure 4 (Morphine 05)

An instructional illustration showing a hand holding a capsule over a toilet bowl, appearing to drop the capsule into the toilet. The image likely represents disposal instructions for the medication Morphine Sulfate extended-release capsules.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Label for Morphine Sulfate Extended-Release Capsules, USP 10 mg, manufactured by Upsher-Smith Laboratories, LLC. The label includes the NDC 0832-0225-00, indicates a package of 100 capsules, and specifies that this is a prescription drug for oral use with extended-release pellets. Storage instructions and a pharmacist advisory to dispense the Medication Guide are included, along with a barcode.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Label for Morphine Sulfate Extended-Release Capsules, USP, 20 mg, manufactured by Upsher-Smith Laboratories, LLC. The label indicates a package of 100 capsules. Instructions state that the medicine is for prescription use only, should be dispensed with a medication guide, and includes storage and handling details to keep the product in a child-resistant and tamper-evident container.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Label for Morphine Sulfate Extended-Release Capsules, USP 30 mg by Upsher-Smith Laboratories, LLC. The label notes it as a once or twice daily formulation, contains 100 capsules, and provides usage, storage, and dispensing information including child resistance and temperature guidelines. The label includes branding and a barcode.*

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Morphine Sulfate Extended-Release Capsules, USP 50 mg in a 100-capsule package from Upsher-Smith Laboratories, LLC. The label includes dosing form as oral capsules, extended-release, with instructions highlighting child-resistant packaging and storage conditions. It bears the NDC 0832-0228-00 and notes the medication guide dispense requirement.*

FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Label for Morphine Sulfate Extended-Release Capsules, USP 60 mg, oral dosage form in capsule, extended release. The label indicates a package size of 100 capsules, labeled for prescription use only, manufactured by Upsher-Smith Laboratories, LLC. It includes usage warnings about not chewing, crushing, or dissolving the pellets, storage conditions, and a medication guide notice for pharmacists.*

FDA Label Image

Principal Display Panel (80 mg Capsule Bottle Label)

Morphine Sulfate Extended-Release Capsules, USP 80 mg, label for oral extended-release capsules. The packaging shows the dosage strength as 80 mg with a quantity of 100 capsules. It is labeled as a prescription drug by Upsher-Smith Laboratories, LLC, Maple Grove, MN. The label includes storage instructions, a warning not to chew or crush pellets, and a request to dispense a Medication Guide to patients.*

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Morphine Sulfate Extended-Release Capsules, USP 100 mg in a 100-capsule package. The label specifies the product is for opioid-tolerant patients only, with a dosage form of extended-release capsules for oral use. The labeler is Upsher-Smith Laboratories, LLC. It includes storage instructions, a medication guide note, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.